Abiopharma

New Form 144 - Butterfly Network, Inc. Filed: 2025-09-03 AccNo: 0001959173-25-005747 Size: 6 KB

New Form SCHEDULE 13G/A - Innoviva, Inc. Filed: 2025-09-03 AccNo: 0001085146-25-005711 Size: 7 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Tamayo Louis Edward 🟢 acquired 325.0K shares (1 derivative) of Lexeo Therapeutics, Inc. (LXEO) at $4.79 ($1.3M) Transaction Date: Aug 29, 2025 | Filing ID: 023491

New Form 144 - Vor Biopharma Inc. Filed: 2025-09-03 AccNo: 0001959173-25-005742 Size: 4 KB

Director SATO VICKI L 🔴 sold 22.0K shares of Vir Biotechnology, Inc. (VIR) at $4.99 Transaction Date: Sep 02, 2025 | Filing ID: 000005

New Form 8-K - Roivant Sciences Ltd. Filed: 2025-09-03 AccNo: 0001140361-25-033767 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form S-1/A - Indaptus Therapeutics, Inc. Filed: 2025-09-03 AccNo: 0001641172-25-026333 Size: 248 KB

New Form 8-K - Immunovant, Inc. Filed: 2025-09-03 AccNo: 0001764013-25-000136 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - NutriBand Inc. Filed: 2025-09-03 AccNo: 0001213900-25-083882 Size: 235 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Chopas James George 🔴 sold 548 shares of Apellis Pharmaceuticals, Inc. (APLS) at $28.08 Transaction Date: Sep 02, 2025 | Filing ID: 021110

Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves Disease Patients

Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves Disease Patients